Archives of Gynecology and Obstetrics

, Volume 287, Issue 2, pp 329–335 | Cite as

Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings

  • Aiping Fan
  • Yingli Yue
  • Nv Geng
  • Huiying Zhang
  • Yingmei Wang
  • Fengxia Xue
General Gynecology



To investigate the clinical features of aerobic vaginitis (AV) and mixed infections with AV to achieve efficient diagnosis.


From April 2008 to August 2009, 657 consecutive outpatients with vaginal symptoms in gynecology clinic in the General Hospital of Tianjin Medical University were investigated. Samples were taken for examination of vaginal discharge and fresh wet mount microscopy. AV, bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomonal vaginitis (TV) were diagnosed according to standardized definitions. Sixty patients with single AV were randomly selected over the same period. Each patient accepted moxifloxacin therapy. Two kinds of treatment course (400 mg qd, 6 days or 400 mg qd, 12 days) were given. Clinical features and laboratory test results in the first visit and follow-ups were recorded and statistically analyzed.


Among the 657 cases, AV was found in 23.74 % of the cases (156/657). AV mixed infections were diagnosed in 53.85 % (84/156): the mixed infections included VVC (32/84, 38.10 %), BV (31/84, 36.90 %), and TV (21/84, 25.00 %). Common symptoms of AV were a change in the characteristics of the discharge (44/72, 61.11 %) and increased discharge (30/72, 41.67 %). Vaginal pH was usually higher than 4.5 (63/72, 87.50 %). Enterococcus faecalis, Streptococcus viridans, Escherichia coli, and Staphylococcus epidermidis were frequently isolated. There is no statistically significant difference between two moxifloxacin treatment groups (p > 0.05). Cure rate was 89.7 % in 6-day group, and 71.4 % in 12-day group.


AV is a common vaginal infection, and it is often mixed with other infections, especially VVC, BV and TV. The symptoms and signs of AV mixed infections are atypical. If a patient has vaginal complaints, it is necessary to determine whether AV or mixed infections are present. Oral moxifloxacin is effective in treating AV, and an appropriate course should be selected taking the severity of AV into consideration.


Aerobic vaginitis Diagnosis Mixed infections Clinical features 


  1. 1.
    Donders GGG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br J Obstet Gynecology 109:1–10CrossRefGoogle Scholar
  2. 2.
    Amsel R, Totten P, Spiegel C, Chen KCS, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Am J Med 74:14–22PubMedCrossRefGoogle Scholar
  3. 3.
    ACOG Committee on Practice Bulletins—Gynecology (2006) ACOG practice bulletin. Clinical management guidelines for obstetrician–gynecologists, Number 72, May 2006: vaginitis. Obstet Gynecol 107(5):1195–1206CrossRefGoogle Scholar
  4. 4.
    Scheffey LC, Rakoff AE, Lang WR (1956) An unusual case of exudative vaginitis (hydrorrhea vaginalis) treated with local hydrocortisone. Am J Obstet Gynecol 72:208–211PubMedGoogle Scholar
  5. 5.
    Gardner HL (1968) Desquamative inflammatory vaginitis. Am J Obstet Gynecol 102(8):1102–1105PubMedGoogle Scholar
  6. 6.
    Mardh PA, Tchoudomirova K, Elshibly S, Hellberg D (1998) Symptoms and sings in single and mixed genital infections. Int J Gynecol Obstet 63:145–152CrossRefGoogle Scholar
  7. 7.
    Govender L, Hoosen AA, Moodley J, Moodley P, Sturm AW (1996) Bacterial vaginosis and associated infections in pregnancy. Int J Gynecol Obstet 55:23–28CrossRefGoogle Scholar
  8. 8.
    Redondo-Lopez V, Meriwether C, Schmitt C, Opitz M, Cook R, Sobel JD (1990) Vulvovaginal candidiasis complicating recurrent bacterial vaginosis. Sex Transm Dis 17:51–53PubMedGoogle Scholar
  9. 9.
    Blackwell A (1987) Infectious causes of abnormal vaginal discharge-part two. Matern Child Health 12:368–375Google Scholar
  10. 10.
    Cepický P, Malina J, Líbalová Z, Kuzelová M (2005) “Mixed” and “miscellaneous” vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel. Ceska Gynekol 70(3):232–237PubMedGoogle Scholar
  11. 11.
    Egan ME, Lipsky MS (2000) Diagnosis of vaginitis. Am Fam Physician 62(5):1095104Google Scholar
  12. 12.
    Sobel JD (1994) Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2 % clindamycin therapy. Am J Obstet Gynecol 171:1215–1220PubMedGoogle Scholar
  13. 13.
    Tempera G, Bonfiglio G, Cammarata E, Corsello S, Cianci A (2004) Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int J Antimicrob Agents 24:85–88PubMedCrossRefGoogle Scholar
  14. 14.
    Tempera G, Abbadessa G, Bonfiglio G, Cammarat E, Cianci A, Corsello S (2006) Topical kanamycin: an effective therapeutic option in aerobic vaginitis. J Chemother 18:409–414PubMedGoogle Scholar
  15. 15.
    Murphy R, Edwards L (2008) Desquamative inflammatory vaginitis: what is it? J Reprod Med 53(2):124–128PubMedGoogle Scholar
  16. 16.
    Peacocke M, Djurkinak E, Thys-Jacobs S (2008) Treatment of desquamative inflammatory vaginitis with Vitamin D: a case report. Cutis 81:75–78PubMedGoogle Scholar
  17. 17.
    Tempera G, Furneri PM (2010) Management of aerobic vaginitis. Gynecol Obstet Invest 70:244–249PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Aiping Fan
    • 1
  • Yingli Yue
    • 1
  • Nv Geng
    • 1
  • Huiying Zhang
    • 1
  • Yingmei Wang
    • 1
  • Fengxia Xue
    • 1
  1. 1.Department of GynecologyTianjin Medical University General HospitalTianjinChina

Personalised recommendations